from web site
Prolotherapy could contribute to the treatment of hypermobility conditions also by preventing the development of precocious osteoarthritis. It has long been understood that people with JHS and EDS suffer with early osteoarthritis in various joints and the quantity of degeneration associates with the level of the people hypermobility. The combination of severe hypermobility and duplicated injury is presumed to be what causes the early osteoarthritis.
While the main author has twenty years experience dealing with JHS and EDS musculoskeletal symptoms with Prolotherapy, future research studies will need to be carried out to finest record the exact role Prolotherapy has in the treatment of the musculoskeletal symptoms and hypermobility of JHS and EDS and if it can avoid future joint degeneration in these people.

2011; 3( 2 ):612 -629. EPIDEMIOLOGY Joint Hypermobility Syndrome (JHS) is a mostly under-recognized and badly comprehended multi-systemic genetic connective tissue condition which manifests in a range of various clinical discussions. Likewise termed You Can Try This Source of connective tissue (HDCT), this is a heterogeneous group of genetically identified diseases, with JHS being a milder variation of Ehlers-Danlos Syndrome (EDS), where gross joint laxity often dominates.
![PDF] Joint Hypermobility Syndrome Affects Response to a Low Fermentable Oligosaccharide, Disaccharide, Monosaccharide and Polyol Diet in Irritable Bowel Syndrome Patients: A Retrospective Study - Semantic Scholar](https://strengthflexibilityhealtheds.com/wp-content/uploads/2015/08/FullSizeRender-211.jpg)
1, 2 While Ehlers-Danlos Syndrome is the most extreme type of hypermobility, numerous others experience comparable conditions such as JHS, and even benign or undiagnosed forms of hypermobility, which provide a number of the same qualities as EDS. Research studies have actually indicated that JHS affects 2%5% of the general population, although it is estimated that 1 in 20 hypermobile patients have actually not been detected for their condition.

5, 6 At present, there are six main known classifications of EDS: Classic, Hypermobility, Vascular, Kyphoscoliosis, Arthrochalasia, and Dermatosparaxis (See Figure 1.) The hypermobility type, which is discovered to be the most common, is approximated to affect one in every 10,000 to 15,000 people. 7 Classic Hypermobility Vascular Kyphoscoliosis Arthrochalasia Dermatosparaxis Skin hyperelasticity Smooth/velvety skin Comprehensive atrophic scarring Extensive bruising Joint hypermobility Reoccurring joint dislocation Vertebral subluxations Chronic joint discomfort Extensive bruising Arterial fragility Intestinal tract fragility Uterine fragility Tendon/ muscle rupture Kyphoscoliosis Arterial rupture Atrophic scars Extreme bruising Osteopenia Genetic hip dislocation Joint hypermobility Reoccurring joint dislocation Tissue fragility Kyphoscoliosis Severe skin fragility Substantial bruising Early rupture of membranes Hernias ETIOLOGY AND PATHOLOGY JHS has a strong hereditary element with an autosomal dominant pattern.